DE69526437D1 - Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens - Google Patents

Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens

Info

Publication number
DE69526437D1
DE69526437D1 DE69526437T DE69526437T DE69526437D1 DE 69526437 D1 DE69526437 D1 DE 69526437D1 DE 69526437 T DE69526437 T DE 69526437T DE 69526437 T DE69526437 T DE 69526437T DE 69526437 D1 DE69526437 D1 DE 69526437D1
Authority
DE
Germany
Prior art keywords
urban
disorders
treatment
available preparation
transdermally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69526437T
Other languages
English (en)
Other versions
DE69526437T2 (de
Inventor
Katsuhiro Nakamura
Nobuyuki Koga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of DE69526437D1 publication Critical patent/DE69526437D1/de
Publication of DE69526437T2 publication Critical patent/DE69526437T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
DE69526437T 1994-05-18 1995-05-18 Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens Expired - Lifetime DE69526437T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12816294 1994-05-18
PCT/JP1995/000946 WO1995031190A1 (fr) 1994-05-18 1995-05-18 Preparation administrable par voie percutanee pour le traitement des troubles de la miction

Publications (2)

Publication Number Publication Date
DE69526437D1 true DE69526437D1 (de) 2002-05-23
DE69526437T2 DE69526437T2 (de) 2002-10-31

Family

ID=14977927

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69526437T Expired - Lifetime DE69526437T2 (de) 1994-05-18 1995-05-18 Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens

Country Status (8)

Country Link
US (1) US5770221A (de)
EP (1) EP0760238B1 (de)
KR (1) KR970703137A (de)
AU (1) AU2454495A (de)
DE (1) DE69526437T2 (de)
DK (1) DK0760238T3 (de)
ES (1) ES2172584T3 (de)
WO (1) WO1995031190A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
US5879701A (en) * 1997-02-28 1999-03-09 Cygnus, Inc. Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
JP4073517B2 (ja) * 1997-04-07 2008-04-09 久光製薬株式会社 経皮吸収貼付剤用粘着剤及び経皮吸収貼付剤
ATE399565T1 (de) * 1998-07-07 2008-07-15 Transdermal Technologies Inc Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung
WO2000053184A1 (fr) * 1999-03-11 2000-09-14 Saitama Daiichi Pharmaceutical Co., Ltd. Composition medicamenteuse a absorption percutanee
WO2000064434A1 (fr) * 1999-04-26 2000-11-02 Lead Chemical Co., Ltd. Preparations percutanees contenant de l'oxybutynine
ID30249A (id) * 1999-08-09 2001-11-15 Yamanouchi Pharma Co Ltd Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah
WO2001021167A1 (en) * 1999-09-22 2001-03-29 Merck & Co., Inc. Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein
ES2281366T3 (es) * 1999-12-15 2007-10-01 Hisamitsu Pharmaceutical Co. Inc. Preparaciomnes de adhesivos.
KR100600456B1 (ko) 2000-04-18 2006-07-13 히사미쓰 세이야꾸 가부시키가이샤 항염증제 함유 첩부제
JP2001328935A (ja) * 2000-05-19 2001-11-27 Hisamitsu Pharmaceut Co Inc 貼付剤
US20020198215A1 (en) * 2000-10-23 2002-12-26 Lino Tavares Terazosin transdermal device and methods
CN1571664A (zh) * 2001-10-17 2005-01-26 久光制药株式会社 经皮吸收型制剂
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
US20060188554A1 (en) * 2003-08-04 2006-08-24 Katashi Nakashima Transdermal absorption preparation
WO2005037946A1 (ja) * 2003-10-20 2005-04-28 Hisamitsu Pharmaceutical Co., Inc. 皮膚外用貼付剤
DE10357321A1 (de) * 2003-12-05 2005-07-21 Tesa Ag Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
JP5208348B2 (ja) * 2004-05-13 2013-06-12 旭化成ファーマ株式会社 ナフトピジルを含有する医薬
KR20130069764A (ko) * 2005-02-03 2013-06-26 교린 세이야꾸 가부시키 가이샤 경피 흡수형 제제
KR20080000647A (ko) * 2005-04-28 2008-01-02 오노 야꾸힝 고교 가부시키가이샤 경피 흡수 제제
JP4921739B2 (ja) * 2005-08-10 2012-04-25 久光製薬株式会社 皮膚刺激を低減した貼付剤
WO2007021008A1 (ja) * 2005-08-19 2007-02-22 Dia Pharmaceutical Co., Ltd. プラスターの製造方法及びその製造装置及びプラスタ－用ライナ－
CN101420946B (zh) * 2006-04-11 2011-05-25 日绊株式会社 含有坦索罗辛的透皮吸收型制剂
US20100092544A1 (en) * 2008-10-14 2010-04-15 Katsuhiro Okada Adhesive composition for patch and use thereof
US20150030666A1 (en) * 2011-11-28 2015-01-29 KM Transderm Ltd. Adhesive skin patch
US10314791B2 (en) * 2014-12-05 2019-06-11 KM Transderm Ltd. Adhesive sheet for attachment to skin and percutaneous absorption preparation using same
WO2018026371A1 (en) * 2016-08-04 2018-02-08 Sunovion Pharmaceuticals Inc. Dual nav1.2/5ht2a inhibitors for treating cns disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
DE3344691A1 (de) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen Wirkstoffabgasesysteme
JPS6145052A (ja) * 1984-08-07 1986-03-04 有限会社　▲カゲ▼山商事 桟瓦
EP0204968B1 (de) * 1985-05-24 1989-09-27 Beiersdorf Aktiengesellschaft Nitro-Pflaster
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US4793337A (en) * 1986-11-17 1988-12-27 E. R. Squibb & Sons, Inc. Adhesive structure and products including same
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
JP2869167B2 (ja) * 1990-08-09 1999-03-10 日東電工株式会社 徐放性貼付製剤
JP3136413B2 (ja) * 1991-02-22 2001-02-19 リードケミカル株式会社 経皮吸収型頻尿・尿失禁治療剤
JPH04273818A (ja) * 1991-02-28 1992-09-30 Kissei Pharmaceut Co Ltd 経皮投与製剤
AU666735B2 (en) * 1992-05-13 1996-02-22 Alza Corporation Transdermal administration of oxybutynin
US5380760A (en) * 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents

Also Published As

Publication number Publication date
DK0760238T3 (da) 2002-07-22
AU2454495A (en) 1995-12-05
ES2172584T3 (es) 2002-10-01
KR970703137A (ko) 1997-07-03
EP0760238A1 (de) 1997-03-05
EP0760238B1 (de) 2002-04-17
EP0760238A4 (de) 1998-06-03
US5770221A (en) 1998-06-23
DE69526437T2 (de) 2002-10-31
WO1995031190A1 (fr) 1995-11-23

Similar Documents

Publication Publication Date Title
DE69526437D1 (de) Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE69922914D1 (de) Stimulationssystem zur Behandlung von Erkrankungen bezüglich des Magenspeiseröhrenreflux
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
ATE280577T1 (de) Oxa-säuren und verwandte verbindungen zur behandlung von störungen der haut
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE59500266D1 (de) Transdermales therapeutisches System zur Applikation von Naloxon
DE69506019D1 (de) Vorrichtung zur Behandlung von Schmerz
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
BR9711225A (pt) Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DE69518438D1 (de) Behandlung von übereregten nervenzellenfunktionen
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WESTENDORP SOMMER, 80336 MUENCHEN